Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations

OBJECTIVE: To investigate the safety and efficacy of rituximab (RTX) in patients with refractory Wegener's granulomatosis (WG). PATIENTS AND METHODS: Eight consecutive patients with active refractory WG were included. In all patients disease activity had persisted despite standard treatment wit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Aries, P M, Hellmich, B, Voswinkel, J, Both, M, Nölle, B, Holl‐Ulrich, K, Lamprecht, P, Gross, W L
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2006
Teme:
Extended Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798224/
https://ncbi.nlm.nih.gov/pubmed/16269425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.044420
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items